Valuation : Zoetis Inc.

Market Cap 30.15B 25.98B 24.6B 22.3B 41.83B 2,881B 42.04B 292B 112B 1,466B 113B 111B 4,631B P/E 2026 *
13x
P/E 2027 * 12.2x
Enterprise Value 37.27B 32.11B 30.41B 27.56B 51.71B 3,561B 51.97B 361B 139B 1,812B 140B 137B 5,725B EV / Sales 2026 *
4.04x
EV / Sales 2027 * 3.86x
Free-Float
82.35%
Yield 2026 *
2.9%
Yield 2027 * 3.1%
1 day-1.73%
1 week-4.22%
Current month-6.41%
1 month-3.70%
3 months-11.78%
6 months-39.74%
Current year-42.99%
1 week 71.5
Extreme 71.5
77
1 month 71
Extreme 71
79
Current year 70
Extreme 70
137.5
1 year 70
Extreme 70
149.69
3 years 70
Extreme 70
201.92
5 years 70
Extreme 70
248
10 years 70
Extreme 70
248
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 53 2026-08-16
Chief Tech/Sci/R&D Officer 49 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-1.73%-4.22% - - 30.15B
+0.15%-3.75%-51.55%-60.78% 30.15B
+1.36%-5.43%+23.38%+96.69% 11.58B
-3.09%-1.28%-13.85%+1.93% 3.88B
+3.15%-2.35%-4.59%+17.55% 3.03B
-2.91%-4.96%+42.04%+24.89% 1.9B
-0.15%-0.29%+9.60%+25.28% 1.87B
-2.62%-6.88%-13.52%+180.25% 1.45B
-3.31%-2.60%-20.82%-6.36% 1.17B
-2.57%-1.01%-7.95%-41.52% 1.04B
Average -1.17%-3.75%-4.14%+26.44% 6.23B
Weighted average by Cap. -0.59%-3.91%-23.29%-6.21%

Financials

2026 *2027 *
Net sales 9.23B 7.96B 7.53B 6.83B 12.81B 882B 12.87B 89.47B 34.41B 449B 34.68B 33.92B 1,418B 9.46B 8.15B 7.72B 7B 13.12B 904B 13.19B 91.66B 35.25B 460B 35.53B 34.75B 1,453B
Net income 2.36B 2.03B 1.93B 1.75B 3.28B 226B 3.29B 22.88B 8.8B 115B 8.87B 8.67B 363B 2.38B 2.05B 1.94B 1.76B 3.3B 228B 3.32B 23.08B 8.87B 116B 8.94B 8.75B 366B
Net Debt 7.12B 6.14B 5.81B 5.27B 9.88B 680B 9.93B 68.99B 26.53B 346B 26.74B 26.16B 1,094B 6.38B 5.5B 5.2B 4.72B 8.85B 609B 8.89B 61.81B 23.77B 310B 23.96B 23.43B 980B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-09-11 US$72.74 -0.76% 11,306
26-09-10 US$73.30 -0.29% 6,429
26-09-09 US$73.51 -1.17% 16,497
26-09-08 US$74.38 -1.23% 9,543
26-09-07 US$75.31 0.00% 134
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
72.97USD
Average target price
96.00USD
Spread / Average Target
+31.56%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!